I am a
Home I AM A Search Login

Papers of the Week

2021 May 07

Int J Obstet Anesth

Quantifying the incidence of clinically significant respiratory depression in women with and without obesity class III receiving neuraxial morphine for post-cesarean analgesia: a retrospective cohort study.


Ende HB, Dwan RL, Freundlich RE, Dumas S, Sorabella LL, Raymond BL, Lozada MJ, Shotwell MS, Wanderer JP, Bauchat JR
Int J Obstet Anesth. 2021 May 07:103187.
PMID: 34053816.


Obesity is a suspected risk factor for respiratory depression following neuraxial morphine for post-cesarean analgesia, however monitoring guidelines for obese obstetric patients are based on small, limited studies. We tested the hypothesis that clinically significant respiratory depression following neuraxial morphine occurs more commonly in women with body mass index (BMI) ≥40 kg/m compared with BMI <40 kg/m.